Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Prime Medicine shares are trading lower after the company reported worse-than-expected Q1 sales results.

benzinga_article

May 7, 2026 at 04:58 PM

Prime Medicine shares are trading lower after the company reported worse-than-expected Q1 sales results.

Source: benzinga_article The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

Sep 10, 2026 at 05:40 AMWorld’s largest contract chipmaker TSMC sees August revenue surge over 53% to record high
Apr 20, 2026 at 06:34 PMEli Lilly Announces $7 Billion Acquisition of Kelonia: Pioneering the 'In Vivo CAR-T' Frontier and Leading Gene Therapy …
Apr 18, 2026 at 12:54 AMIn Just 11 Days, U.S. Stocks Move from 'Oversold' to 'Overbought' — A Rare Occurrence in History
Apr 16, 2026 at 11:12 AMUS Stocks Hit New Highs, Retail Investors Miss Out en masse: Tom Lee Says Next Rally Will Be Led by Them
Apr 13, 2026 at 01:07 AMU.S. Stocks Face a "Final Battle" as Hormuz Outcome Decides the Game: The Rash Never Win, the Patient Prevail

Related Stocks

Prime Medicine

USPRME

-2.53%

Invesco Nasdaq Biotechnology ETF

USIBBQ

SPDR S&P Biotech

USXBI

LongbridgeAI